MedPath

PRINCE Trial Highlights Early Detection of Prostate Cancer Progression with PSMA PET-CT

Michael Hofman discusses developing new PSMA PET-CT criteria for prostate cancer progression evaluation, aiming to replace PCWG3 guidelines. Using PRINCE trial data, his team shows high inter-reader agreement and earlier progression detection with PSMA PET-CT, correlating well with overall survival. Hofman emphasizes the need for contrast-enhanced CT in PSMA PET-CT protocols and plans further validation across multiple trials.


Reference News

PRINCE Trial Highlights Early Detection of Prostate Cancer Progression with PSMA PET-CT

Michael Hofman discusses developing new PSMA PET-CT criteria for prostate cancer progression evaluation, aiming to replace PCWG3 guidelines. Using PRINCE trial data, his team shows high inter-reader agreement and earlier progression detection with PSMA PET-CT, correlating well with overall survival. Hofman emphasizes the need for contrast-enhanced CT in PSMA PET-CT protocols and plans further validation across multiple trials.

© Copyright 2025. All Rights Reserved by MedPath